Inari Medical, Inc. (NARI)

Market Cap	4.67B
Revenue (ttm)	574.50M
Net Income (ttm)	-78.58M
Shares Out	58.74M
EPS (ttm)	-1.35
PE Ratio	n/a
Forward PE	949.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,236,506
Open	79.41
Previous Close	79.40
Day's Range	79.37 - 79.55
52-Week Range	36.73 - 79.69
Beta	0.97
Analysts	Hold
Price Target	69.22 (-12.99%)
Earnings Date	Feb 26, 2025

About NARI

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embol...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 22, 2020
• Employees: 1,300
• Stock Exchange: NASDAQ
• Ticker Symbol: NARI
• Website: https://www.inarimedical.com

Financial Performance

In 2023, Inari Medical's revenue was $493.63 million, an increase of 28.73% compared to the previous year's $383.47 million. Losses were -$1.64 million, -94.41% less than in 2022.

Analyst Forecast

According to 12 analysts, the average rating for NARI stock is "Hold." The 12-month stock price forecast is $69.22, which is a decrease of -12.99% from the latest price.

Price Target

$69.22

(-12.99% downside)

Analyst Consensus: Hold